胶原亲和基质细胞衍生因子SDF1α修饰的优化同种异体脱细胞半月板支架用于半月板再生:兔模型6周和12周动物研究
研究用胶原亲和基质细胞衍生因子SDF1α(C-SDF1α)修饰脱细胞半月板支架(DMS)制备新型半月板移植物DMS-CBD,在体外评估其对人骨髓间充质干细胞的生物相容性与分化诱导性,并在兔内侧半月板切除模型中于术后6周和12周评估半月板再生与软骨保护效果。结果显示DMS-CBD促进细胞迁移和细胞外基质沉积,加速半月板再生并保护关节软骨退变。
要点
- DMS-CBD在体外表现出良好的生物相容性、释放效率及软骨分化诱导性。
- 兔全半月板切除后植入DMS-CBD可促进细胞迁移与细胞外基质沉积。
- DMS-CBD促进半月板再生并保护关节软骨免于退变。
核心结论
- 新型半月板移植物DMS-CBD加速细胞外基质沉积和半月板再生,并保护关节软骨免于退变。
- DMS-CBD移植物可作为半月板切除后的潜在半月板替代物。
研究设计与样本
- 受控实验室研究,先制备C-SDF1α修饰的DMS-CBD移植物,再进行体外和体内实验。
- 体外实验评估释放动力学、生物相容性及对人骨髓间充质干细胞的成骨、成软骨和成肌腱分化诱导性。
- 体内实验对接受内侧半月板切除的兔行DMS-CBD移植,于术后6周和12周通过大体观察、组织学、微力学和免疫组化评估半月板再生与软骨保护效果。
主要发现
- 体外研究中,优化的DMS-CBD移植物表现出显著的生物相容性、释放效率和成软骨诱导性。
- 体内研究中,全半月板切除后植入的DMS-CBD移植物促进移植部位细胞迁移和细胞外基质沉积。
- DMS-CBD进一步促进半月板再生并保护关节软骨免于退变。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Total meniscectomy for treating massive meniscal tears may lead to joint instability, cartilage degeneration, and even progressive osteoarthritis. The meniscal substitution strategies for advancing reconstruction of the meniscus deserve further investigation. HYPOTHESIS: A decellularized meniscal scaffold (DMS) modified with collagen affinity stromal cell-derived factor (C-SDF1α) may facilitate meniscal regeneration and protect cartilage from abrasion. STUDY DESIGN: Controlled laboratory study. METHODS: The authors first modified DMS with C-SDF1α to fabricate a new meniscal graft (DMS-CBD [collagen-binding domain]). Second, they performed in vitro studies to evaluate the release dynamics, biocompatibility, and differentiation inducibility (osteogenic, chondrogenic, and tenogenic differentiation) on human bone marrow mesenchymal stem cells. Using in vivo studies, they subjected rabbits that received medial meniscectomy to a transplantation procedure to implement their meniscal graft. At postoperative weeks 6 and 12, the meniscal regeneration outcomes and chondroprotective efficacy of the new meniscal graft were evaluated by macroscopic observation, histology, micromechanics, and immunohistochemistry tests. RESULTS: In in vitro studies, the optimized DMS-CBD graft showed notable biocompatibility, releasing efficiency, and chondrogenic inducibility. In in vivo studies, the implanted DMS-CBD graft after total meniscectomy promoted the migration of cells and extracellular matrix deposition in transplantation and further facilitated meniscal regeneration and protected articular cartilage from degeneration. CONCLUSION: The new meniscal graft (DMS-CBD) accelerated extracellular matrix deposition and meniscal regeneration and protected articular cartilage from degeneration. CLINICAL RELEVANCE: The results demonstrate that the DMS-CBD graft can serve as a potential meniscal substitution after meniscectomy.
引用
- Zhang T, Shi X, Li M, et al. Optimized Allogenic Decellularized Meniscal Scaffold Modified by Collagen Affinity Stromal Cell-Derived Factor SDF1α for Meniscal Regeneration: A 6- and 12-Week Animal Study in a Rabbit Model. Am J Sports Med. 2024. PMID: 38164676. doi:10.1177/03635465231210950
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。